New drug CS-1103 passes first safety test in healthy volunteers
NCT ID NCT06316973
First seen Nov 10, 2025 · Last updated May 08, 2026 · Updated 28 times
Summary
This early-stage study tested a single dose of the experimental drug CS-1103 in 32 healthy adults to see if it is safe and how the body processes it. The goal is to eventually use CS-1103 to treat methamphetamine abuse or overdose. No treatment was given; researchers only monitored side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.